跳至主要内容
临床试验/NCT03735797
NCT03735797进行中(未招募)不适用

Cancer Stem Cells in Acute Leukemia

Sanford Health1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
50
试验地点
1
主要终点
ARID5B polymorphism/mutation status

研究概览

简要总结

Descriptive study of acute leukemia patients. Bone marrow aspirate or peripheral blood samples will be analyzed by next-generation sequencing for novel gene signatures and variations in transcriptional and epigenetic regulatory elements such as ARID5B and SALL4 variants.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Month 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed or relapsed acute leukemia (AML or ALL)
  • Plan to undergo diagnostic bone marrow aspirate or peripheral blood if clinically indicated (i.e. WBC>50,000 and bone marrow contraindicated)
  • Age 1 month to 30 years
  • Understand and provide informed consent (subject if>18, legal guardian if<18)

排除标准

  • Age 0 to 4 weeks
  • Treatment related leukemia or leukemia secondary to MDS
  • Situations that would limit compliance with study requirements or ability to willingly give consent

结局指标

主要结局

ARID5B polymorphism/mutation status

时间窗: 5 years

Correlation of our experimentally validated Arid5b dependent transcriptional signature with primary patient samples measured by patient ARID5B expression and polymorphisms.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Cancer Stem Cells in Acute Leukemia | 临床试验